314 related articles for article (PubMed ID: 30222681)
1. FDG PET/CT Findings in TAFRO Syndrome.
Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
[TBL] [Abstract][Full Text] [Related]
2. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
3. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
4. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
5. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities.
Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O
Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781
[TBL] [Abstract][Full Text] [Related]
7. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
[TBL] [Abstract][Full Text] [Related]
8. Tufted-angioma-like lesion associated with vascular endothelial growth factor and interleukin-6 in TAFRO syndrome: Is it a common histological feature of multicentric Castleman disease/POEMS syndrome?
Fujita K; Hatta K
J Cutan Pathol; 2019 Apr; 46(4):280-284. PubMed ID: 30632181
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
11. [TAFRO syndrome and monoclonal gammapathy: Uncommon association!].
Naifar M; Messedi M; Elleuch A; Snoussi M; Gouiaa N; Turki M; Lahiani A; Boudawara T; Bahloul Z; Ayedi F
Curr Res Transl Med; 2016; 64(1):43-7. PubMed ID: 27140598
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
14. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
[TBL] [Abstract][Full Text] [Related]
15. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
16. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
[TBL] [Abstract][Full Text] [Related]
17. TAFRO syndrome: 2 cases and review of the literature.
Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
[TBL] [Abstract][Full Text] [Related]
19. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
Wang P; Hou G; Li F; Cheng X
Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
[TBL] [Abstract][Full Text] [Related]
20. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
